Skip to main content
. 2013 Mar 7;144(2):441–449. doi: 10.1378/chest.12-1721

Table 1.

—Patients and Procedural Characteristics

Characteristics Patients
Age, mean (SD), y 59.4 (13.7)
Sex
 Female 27 (38)
 Male 45 (63)
Race
 White 51(71)
 Black 12 (17)
 Hispanic 6 (8)
 Asian 3 (4)
Malignancy type
 Non-small cell lung cancer 32 (44)
 Renal cell 10 (14)
 Sarcoma 6 (8)
 Colon 4 (6)
 Thyroid 4 (6)
 Melanoma 3 (4)
 Breast 2 (3)
 Head and neck 1 (1)
 Small cell 1 (1)
 Lymphoma 1 (1)
 Other solid tumor metastatic to the lung 8 (11)
Smoking status
 Active smoker 5 (7)
 Ex-smoker 44 (61)
 Never smoker 23 (32)
COPD
 Yes 11 (15)
 No 61 (85)
Intraoperative findings at baseline
 Combined extrinsic and endoluminal tumor 36 (50)
 Endoluminal tumor 28 (39)
 Extrinsic compression only 3 (4)
 Other 5 (7)
Indication was for hemoptysisa
 Yes 26 (36)
 No 46 (64)
Indication was obstruction ≥ 50% preprocedurea
 Yes 44 (61)
 No 28 (39)
Indication was obstruction < 50% preprocedurea
 Yes 13 (18)
 No 59 (82)
Stent was placed in this patient
 Yes 24 (33.3)
 No 48 (66.6)
Type of stent placedb (n = 29)
 Ultraflex (Boston Scientific) 15 (52)
 Aero (Merit Medical Systems, Inc) 9 (31)
 Dumon tube stent (Novatech) 1 (3)
 Silicone Y-stent (Novatech) 3 (10)
 Polyflex 1 (3)
Degree of postprocedure airway obstruction
 0%-49% 66 (92)
 50%-100% 6 (8)
Patients had more than one interventional procedure
 Yes 21 (30)
 No 51 (70)
Preprocedure chemotherapy
 Yes 50 (69)
 No 22 (31)
Preprocedure radiation therapy
 Yes 38 (53)
 No 34 (47)
Postprocedure chemotherapy
 Yes 43 (60)
 No 29 (40)
Postprocedure radiation therapy
 Yes 29 (40)
 No 43 (60)

Data are presented as No. (%) unless indicated otherwise.

a

Patients could have more than one indication for intervention.

b

Patients could have more than one interventional procedure and/or more than one stent placed during a single procedure.